Current status of pharmaceutical and genetic therapeutic approaches to treat DMD
Duchenne muscular dystrophy (DMD) is a genetic disease affecting about one in every 3,500 boys. This X-linked pathology is due to the absence of dystrophin in muscle fibers. This lack of dystrophin leads to the progressive muscle degeneration that is often responsible for the death of the DMD patien...
Үндсэн зохиолчид: | Pichavant, C, Aartsma-Rus, A, Clemens, P, Davies, K, Dickson, G, Takeda, S, Wilton, S, Wolff, J, Wooddell, C, Xiao, X, Tremblay, J |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2011
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.
-н: Pichavant, C, зэрэг
Хэвлэсэн: (2011) -
Utrophin upregulation in DMD therapy: current status and new tools for the future
-н: Fairclough, R, зэрэг
Хэвлэсэн: (2011) -
DMD antisense oligonucleotide mediated exon skipping efficiency correlates with flanking intron retention time and target position within the exon
-н: Remko Goossens, зэрэг
Хэвлэсэн: (2023-12-01) -
BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model
-н: SongTing Shi, зэрэг
Хэвлэсэн: (2011-02-01) -
DMD and West syndrome
-н: Cardas, R, зэрэг
Хэвлэсэн: (2017)